79427971
May 6, 2025
Pharmaceutical preparations for use in the treatment of cancer, autoimmune disease, and immune system-related diseases and disorders; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising covalently binding proteins; immunotherapeutic drugs; engineered T cell receptors, for medical purposes; covalently binding proteins, for medical purposes; reagents for medical use; diagnostic reagents for medical use; diagnostic preparations for medical purposes.
Pharmaceuticals